Evidence-based mapping of design heterogeneity prior to meta-analysis: A systematic review and evidence synthesis

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Althuis, Michelle D ^a   Weed, Douglas L ^b   Frankenfeld, Cara L ^c  

^a EpiContext   (United States)

^b DLW Consulting Services LLC   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

Author keywords

Evidence map; Heterogeneity; Meta analysis; Sugar sweetened beverages; Systematic review; Type 2 diabetes

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL RESEARCH; EVIDENCE BASED PRACTICE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; INFORMATION PROCESSING; META ANALYSIS; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SOFT DRINK; SUGAR SWEETENED BEVERAGE; SYSTEMATIC REVIEW; BEVERAGE; INFORMATION RETRIEVAL; LITERATURE; META ANALYSIS (TOPIC); PROCEDURES; SUGAR INTAKE; THEORETICAL MODEL;

SUGAR INTAKE;

BEVERAGES; DIABETES MELLITUS, TYPE 2; DIETARY SUCROSE; HUMANS; INFORMATION STORAGE AND RETRIEVAL; META-ANALYSIS AS TOPIC; MODELS, THEORETICAL; REVIEW LITERATURE AS TOPIC;

EID: 84928034394     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-80     Document Type: Article

References (60)

1. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis 2008, Hoboken, NJ: Wiley.
2. Egger M, Davey Smith G, Schneider M. Systematic reviews of observational studies. Systematic Reviews in Health Care: Meta-analysis in Context 2001, 211-227. London: BMJ Books, Egger M, Davey Smith G, Altman DG, 2.
3. Wong O, Raabe GK. Application of meta-analysis in reviewing occupational cohort studies. Occup Environ Med 1996, 53:793-800.
4. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
5. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999, 28:1-9.
6. Mosteller F, Colditz GA. Understanding research synthesis (meta-analysis). Annu Rev Pub Health 1996, 17:1-23.
7. Thompson SG. Why and how sources of heterogeneity should be investigated. Systematic Reviews in Health Care: Meta-analysis in Context 2001, 157-174. London: BMJ Books, Egger M, Davey Smith G, Altman DG, 2.
8. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994, 309:1351-1355.
9. Deeks JJ, Higgins JPT, Altman DG. Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions 2008, 243-296. Chichester England: Wiley-Blackwell, Higgins JPT, Green S.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
11. McElvenny DM, Armstrong BG, Järup L, Higgins JP. Meta-analysis in occupational epidemiology: a review of practice. Occup Med 2004, 54:336-344.
12. Reeves BC, Higgins JPT, Ramsay C, Shea B, Tugwell P, Wells GA. An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions. Res Syn Meth 2013, 4:1-11.
13. Hannes K, Booth A, Harris J, Noyes J. Celebrating methodological challenges and changes: reflecting on the emergence and importance of the role of qualitative evidence in Cochrane reviews. Syst Rev 2013, 2:84.
14. Althuis MD, Weed DL. Evidence mapping: methodologic foundations and application to intervention and observational research on sugar-sweetened beverages and health outcomes. Am J Clin Nutr 2013, 98:755-768.
15. Callahan P, Liu P, Purcell R, Parker AG, Hetrick SE. Evidence map of prevention and treatment interventions for depression in young people. Depress Res Treat 2012, 2012:820735.
16. Gough D, Thomas J, Oliver S. Clarifying differences between review designs and methods. Syst Rev 2012, 1:28.
17. Bragge P, Clavisi O, Turner T, Tavender E, Collie A, Gruen RL. The global evidence mapping initiative: scoping research in broad topic areas. BMC Med Res Methodol 2011, 17:11-92.
18. Hetrick SE, Parker AG, Callahan P, Purcell R. Evidence mapping: illustrating an emerging methodology to improve evidence-based practice in youth mental health. J Eval Clin Pract 2010, 16:1025-1030.
19. Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implement Sci 2010, 5:69.
20. Liu Y, Wen XM, Lui EL, Friedman SL, Cui W, Ho NP, Li L, Ye T, Fan ST, Zhang H. An evidence map of interventions across premorbid, ultra-high risk and first episode phases of psychosis. Schizophr Res 2010, 123:37-44.
21. Curran C, Burchardt T, Knapp M, McDaid D, Li B. Challenges in multidisciplinary systematic reviewing: a study on social exclusion and mental health policy. Soc Pol Admin 2007, 41:289-312.
22. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Social Research Methodology 2005, 8:19-32.
23. Katz DL, Williams AL, Girard C, Goodman J, Comerford B, Behrman A, Bracken MB. The evidence base for complementary and alternative medicine: methods of evidence mapping with application to CAM. Altern Ther Health Med 2003, 9:22-30.
24. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
25. de Costa Santos CM, de Mattos Pimenta CA, Nobre MR. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem 2007, 15:508-511.
26. Mann J, Cummings JH, Englyst HN, Key T, Liu S, Riccardi G, Summerbell C, Uauy R, van Dam RM, Venn B, Vorster HH, Wiseman M. FAO/WHO scientific update on carbohydrates in human nutrition: conclusions. Eur J Clin Nutr 2007, 61(Suppl 1):S132-S137.
27. Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 2012, 346:e7492.
28. Palmer JR, Boggs DA, Krishnan S, Hu FB, Singer M, Rosenberg L. Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med 2008, 168:1487-1492.
29. Consortium IA. Consumption of sweet beverages and type 2 diabetes incidence in European adults: Results from EPIC-InterAct. Diabetologia 2013, 56:1520-1530.
30. Sluijs I, Beulens JW, van der Schouw YT, van der A DL, Buckland G, Kuijsten A, Schulze MB, Amiano P, Ardanaz E, Balkau B, Boeing H, Gavrila D, Grote VA, Key TJ, Li K, Nilsson P, Overvad K, Palli D, Panico S, Quirós JR, Rolandsson O, Roswall N, Sacerdote C, Sánchez MJ, Sieri S, Slimani N, Spijkerman AM, Tjønneland A, Tumino R, Sharp SJ, et al. InterAct consortium Dietary glycemic index, glycemic load, and digestible carbohydrate intake are not associated with risk of type 2 diabetes in eight European countries. J Nutr 2013, 143:93-99. InterAct consortium.
31. Fagherazzi G, Vilier A, Sartorelli DS, Lajous M, Balkau B, Clavel-Chapelon F. Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the etude epidé miologique auprè s des femmes de la mutuelle Générale de l'education nationale-european prospective investigation into cancer and nutrition cohort. Am J Clin Nutr 2013, 97:517-523.
32. Sluijs I, van der Schouw YT, van der A DL, Spijkerman AM, Hu FB, Grobbee DE, Beulens JW. Carbohydrate quantity and quality and risk of type 2 diabetes in the european prospective investigation into cancer and nutrition-Netherlands (EPIC-NL) study. Am J Clin Nutr 2010, 92:905-911.
33. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Carbohydrate intake and incidence of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)-Potsdam study. Br J Nut 2008, 99:1107-1116.
34. de Koning L, Malik VS, Rimm EB, Willett WC, Hu FB. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr 2011, 93:1321-1327.
35. Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, van Dam RM, Hu FB. Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr 2013, 97:155-166.
36. Meyer KA, Kushi LH, Jacobs DR, Slavin J, Sellers TA, Folsom AR. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000, 71:921-930.
37. Eshak ES, Iso H, Mizoue T, Inoue M, Noda M, Tsugane S. Soft drink, 100% fruit juice, and vegetable juice intakes and risk of diabetes mellitus. Clin Nutr 2013, 32:300-308.
38. Hodge AM, English DR, O'Dea K, Giles GG. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 2004, 27:2701-2706.
39. Bazzano LA, Li TY, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 2008, 31:1311-1317.
40. Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in women. Am J Clin Nutr 1992, 55:1018-1023.
41. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004, 292:927-934.
42. Odegaard AO, Koh WP, Arakawa K, Yu MC, Pereira MA. Soft drink and juice consumption and risk of physician-diagnosed incident type 2 diabetes: The Singapore Chinese health study. Am J Epidemiol 2010, 171:701-708.
43. Janket SJ, Manson JE, Sesso H, Buring JE, Liu S. A prospective study of sugar intake and risk of type 2 diabetes in women. Diabetes Care 2003, 26:1008-1015.
44. Paynter NP, Yeh HC, Voutilainen S, Schmidt MI, Heiss G, Folsom AR, Brancati FL, Kao WH. Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: The atherosclerosis risk in communities study. Am J Epidemiol 2006, 164:1075-1084.
45. Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the multi-ethnic study of atherosclerosis (MESA). Diabetes Care 2009, 32:688-694.
46. Ahmadi-Abhari S, Luben RN, Powell N, Bhaniani A, Chowdhury R, Wareham NJ, Forouhi NG, Khaw KT. Dietary intake of carbohydrates and risk of type 2 diabetes: The european prospective investigation into cancer-Norfolk study. Br J Nutr 2014, 111:342-352.
47. Montonen J, Jarvinen R, Knekt P, Heliovaara M, Reunanen A. Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr 2007, 137:1447-1454.
48. Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Nagasawa SY, Morikawa Y, Ishizaki M, Kido T, Naruse Y, Suwazono Y, Sasaki S, Nakagawa H. Sugar-sweetened beverage and diet soda consumption and the 7-year risk for type 2 diabetes mellitus in middle-aged Japanese men. Eur J Nutr 2014, 53:1137-1138.
49. Lundgren H, Bengtsson C, Blohmé G, Isaksson B, Lapidus L, Lenner RA, Saaek A, Winther E. Dietary habits and incidence of noninsulin-dependent diabetes mellitus in a population study of women in Gothenburg, Sweden. Am J Clin Nutr 1989, 49:708-712.
50. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010, 33:2477-2483.
51. Alhazmi A, Stojanovski E, McEvoy M, Garg ML. Macronutrient intakes and development of type 2 diabetes: a systematic review and meta-analysis of cohort studies. J Am Coll Nutr 2012, 31:243-258.
52. Hauner H, Bechthold A, Boeing H, Brönstrup A, Buyken A, Leschik-Bonnet E, Linseisen J, Schulze M, Strohm D, Wolfram G,. German Nutrition Society Evidence-based guideline of the German Nutrition Society: carbohydrate intake and prevention of nutrition-related diseases. Ann Nutr Metab 2012, 60(Suppl 1):1-58. German Nutrition Society.
53. Jaramillo A, Welch VA, Ueffing E, Gruen RL, Bragge P, Lyddiatt A, Tugwell P. Prevention and self-management interventions are top priorities for osteoarthritis systematic reviews. J Clin Epidemiol 2013, 66:503-510.
54. Greer N, Brasure M, Wilt TJ. Wheeled mobility (wheelchair) service delivery. [http://www.ncbi.nlm.nih.gov/books/NBK83951/].
55. Wysocki A, Butler M, Shamliyan T, Kane RL. Whole-body vibration therapy for osteoporosis. [http://www.ncbi.nlm.nih.gov/books/NBK83043/].
56. Chung M, Dahabreh IJ, Hadar N, Ratichek SJ, Gaylor JM, Trikalinos TA, Lau J. Emerging MRI technologies for imaging musculoskeletal disorders under loading stress. [http://www.ncbi.nlm.nih.gov/books/NBK82287/].
57. Norris SL, Moher D, Reeves BC, Shea B, Loke Y, Garner S, Anderson L, Tugwell P, Wells G. Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions. Res Syn Meth 2013, 4:36-47.
58. Priebe MG, van Binsbergen JJ, de Vos R, Vonk RJ. Whole grain foods for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 2008, 1. CD006061.
59. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 2012, 142:1304-1313.
60. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 2007, 4:e261.